Surveying proteolytic processes in human cancer microenvironments by microdialysis and activity-based mass spectrometry

Proteomics - Clinical Applications

Volumn 5, Issue 11-12, 2011, Pages 636-643

  Hardt, Markus ^a   Lam, David K ^b   Dolan, John C ^c   Schmidt, Brian L ^c  

^a BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

Cancer; Microdialysis; Pain

Indexed keywords

GELATINASE B; NEUROTRYPSIN; NEUTROPHIL COLLAGENASE; OXYGEN 18; PROTEINASE; TRYPSIN; TRYPSIN 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EX VIVO STUDY; FREEZE DRYING; HUMAN; HUMAN TISSUE; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU MICRODIALYSIS; INTERSTITIAL FLUID; INTRAOPERATIVE PERIOD; MASS SPECTROMETRY; MOUTH CARCINOMA; ORAL SURGERY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEOMICS; REHYDRATION; TUMOR MICROENVIRONMENT;

AMINO ACID SEQUENCE; CARCINOMA, SQUAMOUS CELL; HUMANS; MASS SPECTROMETRY; MICRODIALYSIS; MOLECULAR SEQUENCE DATA; MOUTH NEOPLASMS; PROTEOLYSIS; TUMOR MICROENVIRONMENT;

EID: 84855178340     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201100015     Document Type: Article

References (26)

1. Koblinski, J., Ahram, M., Sloane, B., Unraveling the role of proteases in cancer. Clin. Chim. Acta 2000, 291, 113-135.
2. DeClerck, Y. A., Mercurio, A. M., Stack, M. S., Chapman, H. A. et al., Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am. J. Pathol. 2004, 164, 1131-1139.
3. Kessenbrock, K., Plaks, V., Werb, Z., Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141, 52-67.
4. Huang, C.-M., In vivo secretome sampling technology for proteomics. Proteomics Clin. Appl. 2007, 1, 953-962.
5. Xue, H., Lu, B., Lai, M., The cancer secretome: A reservoir of biomarkers. J. Transl. Med. 2008, 6, 52.
6. Schmidt, B. L., Hamamoto, D. T., Simone, D. A., Wilcox, G. L., Mechanism of cancer pain. Mol. Interv. 2010, 10, 164-178.
7. Robinson, S., Niles, R. K., Witkowska, H. E., Rittenbach, K. J. et al., A mass spectrometry-based strategy for detecting and characterizing endogenous proteinase activities in complex biological samples. Proteomics 2008, 8, 435-445.
8. Miyagi, M., Rao, K. C. S., Proteolytic 18O-labeling strategies for quantitative proteomics. Mass Spectrom. Rev. 2007, 26, 121-136.
9. Mason, S. D., Joyce, J. A., Proteolytic networks in cancer. Trends Cell Biol. 2011, 21, 228-237.
10. Huang, D. W., Sherman, B. T., Lempicki, R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4, 44-57.
11. Overall, C. M., Kleifeld, O., Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat. Rev. Cancer 2006, 6, 227-239.
12. McColl, B. K., Baldwin, M. E., Roufail, S., Freeman, C. et al., Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. J. Exp. Med. 2003, 198, 863-868.
13. Rutkowski, M. J., Sughrue, M. E., Kane, A. J., Mills, S. A., Parsa, A. T., Cancer and the complement cascade. Mol. Cancer Res. 2010, 8, 1453-1465.
14. auf dem Keller, U., Doucet, A., Overall, C. M., Protease research in the era of systems biology. Biol. Chem. 2007, 388, 1159-1162.
15. Rawlings, N. D., Barrett, A. J., Bateman, A., MEROPS: The peptidase database. Nucleic Acids Res. 2010, 38, D227-D233.
16. Arbeláez, L. F., Bergmann, U., Tuuttila, A., Shanbhag, V. P., Stigbrand, T., Interaction of matrix metalloproteinases-2 and -9 with pregnancy zone protein and alpha2-macroglobulin. Arch. Biochem. Biophys. 1997, 347, 62-68.
17. Barrett, A. J., Alpha 2-macroglobulin. Methods Enzymol. 1981, 80, 737-754.
18. Michaelis, J., Vissers, M. C., Winterbourn, C. C., Human neutrophil collagenase cleaves alpha 1-antitrypsin. Biochem. J. 1990, 270, 809-814.
19. van Winden, A. W., van den Broek, I., Gast, M. C., Engwegen, J. Y. et al., Serum degradome markers for the detection of breast cancer. J. Proteome Res. 2010, 9, 3781-3788.
20. Campbell, D. J., The renin-angiotensin and the kallikrein-kinin systems. Int. J. Biochem. Cell Biol. 2003, 35, 784-791.
21. Marnett, A., Craik, C. S., Papa's got a brand new tag: Advances in identification of proteases and their substrates. Trends Biotechnol. 2005, 23, 59-64.
22. Coffelt, S. B., Scandurro, A. B., Tumors sound the alarmin(s). Cancer Res. 2008, 68, 6482-6485.
23. Gallucci, S., Matzinger, P., Danger signals: SOS to the immune system. Curr. Opin. Immunol. 2001, 13, 114-119.
24. Ralhan, R., Masui, O., Desouza, L. V., Matta, A. et al., Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: strategy for discovery of candidate serological biomarkers. Proteomics 2011, 11, 2363-2376.
25. Xu, J., Zhang, X., Pelayo, R., Monestier, M. et al., Extracellular histones are major mediators of death in sepsis. Nat. Med. 2009, 15, 1318-1321.
26. Cravatt, B. F., Wright, A., Kozarich, J., Activity-based protein profiling: from enzyme chemistry to proteomic chemistry. Annu. Rev. Biochem. 2008, 77, 383-414.